David Charles Baker - Net Worth and Insider Trading
David Charles Baker Net Worth
The estimated net worth of David Charles Baker is at least $106,116 dollars as of 2024-11-05. David Charles Baker is the CEO of Vallon Pharmaceuticals Inc and owns about 8,843 shares of Vallon Pharmaceuticals Inc (VLON) stock worth over $106,116. Details can be seen in David Charles Baker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Charles Baker has not made any transactions after 2021-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Charles Baker
David Charles Baker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Charles Baker owns 2 companies in total, including Vallon Pharmaceuticals Inc (VLON) , and GRI Bio Inc (GRI) .
Click here to see the complete history of David Charles Baker’s form 4 insider trades.
Insider Ownership Summary of David Charles Baker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VLON | Vallon Pharmaceuticals Inc | 2021-02-12 | director & Chief Executive Officer |
| GRI | GRI Bio Inc | 2021-02-09 | director & Chief Executive Officer |
David Charles Baker Latest Holdings Summary
David Charles Baker currently owns a total of 1 stock. David Charles Baker owns 8,843 shares of Vallon Pharmaceuticals Inc (VLON) as of February 12, 2021, with a value of $106,116.
Latest Holdings of David Charles Baker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VLON | Vallon Pharmaceuticals Inc | 2021-02-12 | 8,843 | 12.00 | 106,116 |
Holding Weightings of David Charles Baker
David Charles Baker Form 4 Trading Tracker
According to the SEC Form 4 filings, David Charles Baker has made a total of 1 transactions in Vallon Pharmaceuticals Inc (VLON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vallon Pharmaceuticals Inc is the acquisition of 1,000 shares on February 12, 2021, which cost David Charles Baker around $8,000.
Insider Trading History of David Charles Baker
- 1
David Charles Baker Trading Performance
GuruFocus tracks the stock performance after each of David Charles Baker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Charles Baker is -52.11%. GuruFocus also compares David Charles Baker's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Charles Baker within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Charles Baker's insider trading performs compared to the benchmark.
Performance of David Charles Baker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -28.99 | | | | | |
| Relative Return to S&P 500(%) | -29.1 | | | | | |
David Charles Baker Ownership Network
Ownership Network List of David Charles Baker
Ownership Network Relation of David Charles Baker
David Charles Baker Owned Company Details
What does Vallon Pharmaceuticals Inc do?
Who are the key executives at Vallon Pharmaceuticals Inc?
David Charles Baker is the director & Chief Executive Officer of Vallon Pharmaceuticals Inc. Other key executives at Vallon Pharmaceuticals Inc include Chief Financial Officer Leanne M. Kelly , 10 percent owner Arcturus Therapeutics Holdings Inc. , and SVP & Regul Affairs & Prog Mgmt Penny Toren .
Vallon Pharmaceuticals Inc (VLON) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Vallon Pharmaceuticals Inc (VLON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vallon Pharmaceuticals Inc (VLON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Vallon Pharmaceuticals Inc (VLON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vallon Pharmaceuticals Inc Insider Transactions
David Charles Baker Mailing Address
Above is the net worth, insider trading, and ownership report for David Charles Baker. You might contact David Charles Baker via mailing address: 100 N. 18th Street, Suite 300, Philadelphia Pa 19103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
